Anacetrapib

From Citizendium
Revision as of 08:28, 22 November 2010 by imported>Robert Badgett (New page: In health care, '''anacetrapib''' (anacet'rapib) is a oxazolidinone medication that is a cholesteryl ester transfer protein inhibitor that raises HDL cholesterol and reduces [[...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

In health care, anacetrapib (anacet'rapib) is a oxazolidinone medication that is a cholesteryl ester transfer protein inhibitor that raises HDL cholesterol and reduces LDL cholesterol.[1]

Anacetrapib is related to torcetrapib.[2]

References

  1. ↑ Anonymous (2024), Anacetrapib (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. ↑ Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM et al. (2010). "Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease.". N Engl J Med. DOI:10.1056/NEJMoa1009744. PMID 21082868. Research Blogging.
Retrieved from "https://citizendium.org/wiki/index.php?title=Anacetrapib&oldid=812468"